» Articles » PMID: 38788006

Mechanism and Clinical Role of TIMP-2 and IGFBP-7 in Cardiac Surgery-associated Acute Kidney Injury: A Review

Overview
Specialty General Medicine
Date 2024 May 24
PMID 38788006
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is a common postoperative complication, but there is still a lack of accurate biomarkers. Cardiac surgery-associated AKI is the most common cause of major-surgery-related AKI, and patients requiring renal replacement therapy have high mortality rates. Early diagnosis, intervention, and management are crucial for improving patient prognosis. However, diagnosing AKI based solely on changes in serum creatinine level and urine output is insufficient, as these changes often lag behind actual kidney damage, making early detection challenging. Biomarkers such as tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein-7 (IGFBP-7) have been found to be significant predictors of moderate-to-severe AKI when combined with urine content analysis. This article reviews the mechanism of biomarkers TIMP-2 and IGFBP-7 in AKI and provides a comprehensive overview of the clinical effects of TIMP-2 and IGFBP-7 in cardiac surgery-associated AKI, including prediction, diagnosis, and progression.

References
1.
Maia J, Rodrigues A, Dias A, Azevedo B, Leite-Moreira A, Lourenco A . Kidney Injury after Cardiac Surgery: Prevention-Associated Cost Reduction. Acta Med Port. 2023; 36(9):567-587. DOI: 10.20344/amp.18755. View

2.
Joannidis M, Forni L, Haase M, Koyner J, Shi J, Kashani K . Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury. Crit Care Med. 2019; 47(10):e820-e826. PMC: 6750148. DOI: 10.1097/CCM.0000000000003907. View

3.
Zarbock A, Kullmar M, Ostermann M, Lucchese G, Baig K, Cennamo A . Prevention of Cardiac Surgery-Associated Acute Kidney Injury by Implementing the KDIGO Guidelines in High-Risk Patients Identified by Biomarkers: The PrevAKI-Multicenter Randomized Controlled Trial. Anesth Analg. 2021; 133(2):292-302. DOI: 10.1213/ANE.0000000000005458. View

4.
Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K . Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014; 9(3):e93460. PMC: 3968141. DOI: 10.1371/journal.pone.0093460. View

5.
Gunnerson K, Shaw A, Chawla L, Bihorac A, Al-Khafaji A, Kashani K . TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg. 2016; 80(2):243-9. PMC: 4729326. DOI: 10.1097/TA.0000000000000912. View